Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 25, 18:14 PM 2012  
FNMFO KDDIF 096770 AMKBF CTGBZ AU 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for CHBT

ChinaBiotics quote and profile

    
0.0
  
STOCK
 0.00   No Change   0.00%  

ChinaBiotics Alert!

ChinaBiotics Inc. cannot be verified agains its exchange. It seems like ChinaBiotics is not available for investing. Please verify the symbol is currently traded on American Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.

1 Month Beta ..........

1.07
ChinaBiotics returns are very sensitive to returns on the market. As market goes up or down, ChinaBiotics is expected to follow.
ChinaBiotics Inc. llmost one Beta
CHBT United States AMEX
ChinaBiotics Inc.
 
Trade ChinaBiotics
Number of Employees6
 thisGreen CHBT CHBT agains markets  0.00 % No Change  
 
 United States NASDAQ   0.07 % Macroaxis: 0.07 Moved Down  
 
 United States SP 500   0.22 % Macroaxis: 0.22 Moved Down  
 
 United States NYSE   0.24 % Macroaxis: 0.24 Moved Down  
 

ChinaBiotics correlation with market

Significant diversification
Overlapping area represents amount of risk that can be diversified away by holding ChinaBiotics Inc. and equity matching GSPC index in the same portfolio

Try other equities

United States CH  Aberdeen Chile Fund Inc.  Stock  AMEX 
United States AMNN  China Agricorp Inc  OTC Equity  OTC BB 
United States CVVT  China Valves Technology Inc.  Stock  AMEX 
United States CHNWE  CHINA OPPY ACQ CORP WRT 2011  OTC Equity  OTC BB 
United States CHMO  China Mobile Media Technology Inc.  OTC Stock  Pink Sheets 

ChinaBiotics Performance

    
Price Growth (%)   
ChinaBiotics  Market  
 
Timeline
    

ChinaBiotics 30-Days Risk-Return Take

    
If you would invest 143.00 in ChinaBiotics Inc. on April 25, 2012 and sell it today you would lose (64.00) from holding ChinaBiotics Inc. or give up 44.76% of portfolio value over 30 days. ChinaBiotics Inc. is currenly does not generate positive expected returns and assumes 10.85% risk (volatility on return distribution) over the 30 days horizon. In different words, most equities are less risky than ChinaBiotics Inc. and most traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
Risk [Daily Volatility] (%)
Given investment horizon of 30 days, ChinaBiotics Inc. is expected to under-perform the market. In addition to that, the company is 14.28 times more volatile than its market benchmark. It trades about -0.16 of its total potential returns per unit of risk. The NYSE is currently generating roughly -0.39 per unit of volatility.
    

Discuss ChinaBiotics quote and profile

       
       
    
    
ChinaBiotics
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days ChinaBiotics Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    

Promote ChinaBiotics

    
Follow ChinaBiotics with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add ChinaBiotics to your reader
 
Get social with ChinaBiotics
 Get social with ChinaBiotics 
Share Toggle social options for ChinaBiotics
    

Add ChinaBiotics to Your Portfolio

    
Sign in to add this equity to your portfolios   
  
 
    

ChinaBiotics Research Report

    
    



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting